The second day of 14th National Conference on Cardiodiabetology discussed miraculous drugs and revolutionary techniques which will make life of patients of diabetes and heart disease easy.
Speaking on anti-diabetic medications Dr PC Manoria said that after research of 100 years two new drugs SGlT2 inhibitors and GlP-1 agonist liraglutide have shown for the first time improvement in CV outcomes and mortality. The SGlT2 inhibitors act in a unique way by increasing passage glucose in urine and liraglutide increases levels of incretin hormones. He further said that PCSK9 inhibitors has come as a wonder drug for patient of heart attack and decreases cholesterol effectively to low levels.
Dr Pankaj Manoria said that new drugs like prasurgrel and ticagrelor which decrease stickiness of the blood are very useful in management of patients of heart attack. They optimize the results of angioplasty, decreases mortality and minimizes the risk of blockage of stents in future.
Dr Kriplani from Mumbai spoke on acute kidney injury in intensive care and highlighted various ways by which this can be prevented. He also outlined the treatment of hypertension in renal diseases. Dr Mona Bhatia from Mumbai spoke on utility of MRI in myocardial diseases and said this is the gold standard for this subset of patient and in several cases provides better information that echocardiography.
Dr OP Yadav from Delhi highlighted the role of surgery and catheter interventions in valvular heart diseases and said that currently aortic valve implantation can now be done successfully with these techniques without resorting to surgery. Dr SB Gupta from Mumbai highlighted the role of ambulatory blood pressure monitoring and said that this technique is very useful in and optimum control of blood pressure. Post Graduates in large numbers from different colleges of the country presented several research papers which were widely appreciated.
The programme was largely attended by delegates from all over the country.